New Geisinger Partnership Will Help Build Bigger Biobank of Tumor Samples

Geisinger Health System is partnering with Indivumed, a developer for individualized oncology technology, to bank and quickly preserve samples from consenting tumor removal surgery patients. Indivumed will be able to analyze the tissue samples to ultimately aid in the development of new therapies. By integrating Indivumed’s large data and tissue biobank at Geisinger, the developer and the health system hope to help clinical researchers understand the biological differences between tumors and how patients respond to treatments.